New England Journal of Medicine· 2012Q1· Clinical trial

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg et al.

5,511citations
Q1SCImago
2012year

Short summary

Preoperative chemoradiotherapy followed by surgery significantly improved median overall survival by over 25 months compared to surgery alone for patients with potentially curable esophageal or esophagogastric-junction cancer.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Surgery

SurgeryMedicine